| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918268 | Radiotherapy and Oncology | 2014 | 7 Pages |
Abstract
Carboplatin-based CRT is associated with similar long-term survival but lower rates of toxicity. These findings suggest carboplatin may be the most appropriate chemotherapeutic agent for elderly stage III patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nicole Ezer, Cardinale B. Smith, Matthew D. Galsky, Grace Mhango, Fei Gu, Jorge Gomez, Gary M. Strauss, Juan Wisnivesky,